Transform Your Health with a Collaborative GLP-1 Program
Personalized guidance, medically supervised plans, and
science-backed strategies to help you thrive on your journey to better health.
GLP-1 Medications:
A Comprehensive Introduction
​
What Are GLP-1s and How Do They Work?
Glucagon-Like Peptide-1 (GLP-1) receptor agonists are medications that mimic a natural hormone produced in your gut. This hormone plays a key role in regulating blood sugar, controlling appetite, and supporting metabolic health.
​
GLP-1s work in several ways:
-
They enhance insulin secretion—helping your body use sugar more effectively and keeping blood sugar levels in check
-
They slow down gastric emptying, so food stays in your stomach longer. This helps you feel fuller for longer and reduces cravings.
-
They communicate with your brain’s appetite centers, naturally reducing your desire to eat and making it easier to make healthier choices.
In simple terms, GLP-1 medications help restore balance in your metabolism, making it easier to achieve and maintain a healthy weight while improving overall health.
​
GLP-1s: A Tool in Your Health Toolbox
It's important to view GLP-1 medications as one component of a comprehensive health strategy. They are not replacements for healthy eating and regular exercise but can serve as effective tools to enhance metabolic health when used in conjunction with lifestyle modifications.
​Why Steamboat Fit Created This Program
​
​
At Steamboat Fit, we believe that health, longevity, exercise, and movement are the foundation of a vibrant life. Over the past year, we’ve worked in collaboration with local doctors to deeply understand GLP-1 medications—their risks, benefits, and the best ways to safely integrate them into a comprehensive health plan.
​
What we’ve seen time and time again is that GLP-1s can be a powerful tool for many individuals—not just for weight loss, but to truly improve metabolic health. We’ve supported clients who have been exercising and eating well, but who couldn’t get the scale to budge. When combined with the right medical support, these medications have helped unlock new progress and improvements.
​
This program is not a quick fix. It’s a way to help those who struggle with obesity, insulin resistance, and other metabolic challenges by adding another valuable tool to their health journey.
​
We’re proud to offer this program in partnership with local physicians. These doctors handle all medical aspects, including prescriptions and lab work, while Steamboat Fit provides the ongoing coaching and accountability you need to succeed. Your weekly meetings with our health coach will align seamlessly with your physician’s oversight and support, ensuring a comprehensive and collaborative approach.
​
We’ve carefully selected doctors who share our values—physicians who provide holistic care, thoroughly review labs to ensure you’re a good candidate, and monitor your health throughout. Together, we’re here to help you thrive.
Health Benefits Beyond Weight Loss
​
While GLP-1s are well-known for supporting weight loss, research highlights several additional health benefits:
​
-
Cardiovascular Health: GLP-1 receptor agonists have been shown to reduce the risk of major adverse cardiovascular events, including heart attacks and strokes, in individuals with type 2 diabetes.
​
-
Neuroprotective Effects: Studies suggest that GLP-1 receptor agonists may lower the risk of developing neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.
​
-
Kidney Function: Evidence indicates that GLP-1 receptor agonists can significantly reduce the progression of kidney disease in patients with type 2 diabetes.
​
-
Anti-Inflammatory and Immune Support: GLP-1 receptor agonists have demonstrated anti-inflammatory properties and may modulate the immune response, offering potential benefits in treating autoimmune conditions.
​
Addressing Common Concerns About Side Effects
You may have heard about some negative side effects of GLP-1 medications in the media, such as nausea or gastrointestinal discomfort. These side effects often occur when treatment is initiated at a dose that's too high. Our approach in collaboration with our physician team, is start with a low dose and gradually increase it, which has been effective in minimizing side effects and improving client outcomes.
Meet Rebecca Williams, GLP-1 Health Coach
​
Menopause Nutrition Specialist | Certified Nutrition Coach | GLP-1 Exercise Specialist
NASM Weight Loss Specialist| Certified Personal Trainer | Cancer Exercise Specialist
​​
Rebecca is the owner of Steamboat Fit and a nationally certified personal trainer and nutrition coach. She is a Menopause Nutrition Specialist with advanced training in hormone health, body composition, and functional fitness. Rebecca incorporates her training under Dr. Stacy Sims’ Menopause Nutrition course and draws on research from other leading experts to create a well-rounded, science-backed program that supports women through perimenopause, menopause, and post-menopause.
​
She also follows the GLP-1 Optimizer Protocol, incorporating trainings from Dr. Tyna Moore’s program on microdosing and dosing strategies to ensure that clients start with the right dosage, minimize side effects, and achieve sustainable health outcomes. Rebecca has partnered with numerous local doctors to design effective, medically supervised plans for clients using medications like Ozempic, Wegovy, Mounjaro, or Zepbound. In addition, she is a certified GLP-1 Exercise Specialist, helping clients preserve muscle mass, improve energy, and stay active throughout their medical weight loss journey.
​
A key part of Rebecca’s approach is focused on GLP-1 nutrition strategies, helping clients learn how to fuel their bodies properly, support muscle retention, and maintain healthy metabolic function while using GLP-1 medications.
​
Rebecca’s approach is rooted in research and designed to be empowering, sustainable, and tailored to each client’s unique lifestyle and goals.
Research and References:
​
Cardiovascular Benefits
Kristensen SL, Rørth R, Jhund PS, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes Endocrinol. 2019;7(10):776-785. https://pubmed.ncbi.nlm.nih.gov/31422062/
​
Neuroprotective Effects
Wang Y, Liu Y, Li J, et al. Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative diseases: a review. Front Aging Neurosci. 2021;13:645870. https://pubmed.ncbi.nlm.nih.gov/34144086/
​
Renal Protection
Mann JFE, Ørsted DD, Brown-Frandsen K, et al. Liraglutide and renal outcomes in type 2 diabetes. N Engl J Med. 2017;377(9):839-848. https://pubmed.ncbi.nlm.nih.gov/28846097/
Anti-Inflammatory Properties
Lee CH, Jeon SJ, Cho KS, et al. Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation. Mol Neurobiol. 2018;55(4):3007-3020. https://pubmed.ncbi.nlm.nih.gov/28456941/
Metabolic Health and Weight Management
Nauck MA, Meier JJ. Incretin hormones: Their role in health and disease. Diabetes Obes Metab. 2018;20(Suppl 1):5-21. https://pubmed.ncbi.nlm.nih.gov/29405399/
Potential in Neurodegenerative Diseases
Hölscher C. GLP-1 receptor agonists in neurodegeneration: potential and hope. Neuropharmacology. 2020;136:238-248. https://pubmed.ncbi.nlm.nih.gov/30938196/
GLP-1 and Inflammatory Skin Diseases
Kanie T, Mizuno A, Takaoka Y, et al. The effects of GLP-1RA on inflammatory skin diseases. Cochrane Database Syst Rev. 2021;10(10):CD013650. https://pubmed.ncbi.nlm.nih.gov/34693515/
Kidney Health in Diabetes
Tuttle KR, Lakshmanan MC, Rayner B, et al. Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial. Lancet Diabetes Endocrinol. 2018;6(8):605-617. https://pubmed.ncbi.nlm.nih.gov/29859865/
GLP-1 and Cardiovascular Outcomes
Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311-322. https://pubmed.ncbi.nlm.nih.gov/27295427/
GLP-1 and Neuroinflammation
Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018;27(4):740-756. https://pubmed.ncbi.nlm.nih.gov/29617647/
​